König, L.; Hörner-Rieber, J.; Forsthoefel, M.; Haering, P.; Meixner, E.; Eichkorn, T.; Krämer, A.; Mielke, T.; Tonndorf-Martini, E.; Haefner, M.F.;
et al. Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers 2022, 14, 2409.
https://doi.org/10.3390/cancers14102409
AMA Style
König L, Hörner-Rieber J, Forsthoefel M, Haering P, Meixner E, Eichkorn T, Krämer A, Mielke T, Tonndorf-Martini E, Haefner MF,
et al. Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers. 2022; 14(10):2409.
https://doi.org/10.3390/cancers14102409
Chicago/Turabian Style
König, Laila, Juliane Hörner-Rieber, Matthew Forsthoefel, Peter Haering, Eva Meixner, Tanja Eichkorn, Anna Krämer, Thomas Mielke, Eric Tonndorf-Martini, Matthias F. Haefner,
and et al. 2022. "Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk" Cancers 14, no. 10: 2409.
https://doi.org/10.3390/cancers14102409
APA Style
König, L., Hörner-Rieber, J., Forsthoefel, M., Haering, P., Meixner, E., Eichkorn, T., Krämer, A., Mielke, T., Tonndorf-Martini, E., Haefner, M. F., Debus, J., & Lischalk, J. W.
(2022). Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk. Cancers, 14(10), 2409.
https://doi.org/10.3390/cancers14102409
